Condition

PD-1 Inhibitor clinical trials and research

• 9Clinical trials
• 1Country

Newest PD-1 Inhibitor clinical trials

All recruiting trials (9)

• Low-dose local radiotherapy plus pucotenlimab with standard chemotherapy for advanced pancreatic cancer

  This trial tests whether adding low-dose local radiation and the PD-1 blocker pucotenlimab to standard chemotherapy can help people with advanced, unresectable pancreatic cancer.

  Recruiting Phase 1/2 Zhejiang Provincial People's Hospital · Hangzhou, Zhejiang · NCT07312422

• Nephron-sparing tislelizumab and nab-paclitaxel for renal pelvic cancer

  This study will try combining tislelizumab and nab‑paclitaxel to shrink HER‑2–expressing renal pelvic tumors in adults eligible for ureteroscopic laser ablation.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin, Outside U.S. · NCT07233252

• Neoadjuvant tislelizumab plus nab‑paclitaxel before radical nephroureterectomy for upper tract urothelial carcinoma

  This will test whether giving the PD‑1 drug tislelizumab together with nab‑paclitaxel before surgery helps people with non‑metastatic upper tract urothelial carcinoma.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin, Outside U.S. · NCT07126119

• Neoadjuvant tislelizumab plus nab‑paclitaxel before kidney‑sparing distal ureterectomy for ureteral cancer

  This will try giving people with non‑metastatic ureteral cancer two to three cycles of tislelizumab plus nab‑paclitaxel before a kidney‑sparing distal ureterectomy to see if tumor response improves and the treatment is tolerable.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin, Outside U.S. · NCT07125547

• Comparing two and three cycles of chemotherapy with immunotherapy for advanced nasopharyngeal cancer

  This study is testing whether two cycles of chemotherapy combined with immunotherapy can help people with advanced nasopharyngeal cancer just as much as three cycles, but with fewer side effects.

  Recruiting at 3 sites Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian and 2 other locations · NCT06811844

• Combining low dose brain radiotherapy with immunotherapy and intrathecal chemotherapy for lung cancer

  This study is testing a new treatment that combines low dose brain radiation, immune therapy, and chemotherapy to see if it helps people with tough lung cancer that has spread to the brain.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT06431685

• Combining chemotherapy and targeted therapy for advanced liver cancer

  This study is testing whether combining a specific type of chemotherapy with two targeted therapies can help people with advanced liver cancer feel better and improve their treatment results.

  Recruiting Sun Yat-sen University · Beijing, Beijing Municipality · NCT06333561

• Neoadjuvant therapy for resectable esophageal squamous cell carcinoma

  This study is testing if a new combination of treatments can help people with operable esophageal cancer do better than the usual chemotherapy before surgery.

  Recruiting at 3 sites Phase 2 Tang-Du Hospital · Xi'an, Shaanxi and 2 other locations · NCT06006650

• Predicting the effectiveness of PD-1 monoclonal antibody treatment for advanced esophageal cancer

  This study is trying to see if changes in immune cells can help predict how well PD-1 antibody treatment works for people with advanced esophageal cancer.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou · NCT05392413

Related topics

Quick answers

How many PD-1 Inhibitor clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →